Company News, Financial News

Croda International Acquires Solus Biotech

South Korean firm specializes in ceramide and phospholipid technologies.

Author Image

By: TOM BRANNA

Editor

Croda International PLC agreed to buy Solus Biotech from Solus Advanced Materials Co. The purchase price is nearly $280 million at current exchange rates. The move expands Croda’s Asian manufacturing capability. Based in South Korea, Solus Biotech produces biotech-derived ceramide and phospholipid technologies, and natural retinol. According to Croda, Solus is a leading supplier of naturally derived powder ceramides, a high-growth global market with further potential to extend into formulated...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters